^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

methylprednisolone oral

Associations
Company:
Generic mfg.
Drug class:
GCR agonist
Associations
21d
Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis (clinicaltrials.gov)
P=N/A, N=30, Recruiting, Assiut University | Trial completion date: Dec 2025 --> Apr 2026 | Trial primary completion date: Dec 2025 --> Mar 2026
Trial completion date • Trial primary completion date
|
methylprednisolone oral • methylprednisolone sodium succinate
1m
A Rare Case of Polyserositis With Elevated Serum Cancer Antigen (CA)-125 in Systemic Lupus Erythematosus: A Case Report of Pseudo-Pseudo Meigs Syndrome. (PubMed, Cureus)
Her symptoms were well-controlled with prednisolone and hydroxychloroquine. She presented with a history of shortness of breath, diffuse abdominal pain, and abdominal distension...The patient was treated initially with furosemide without improvement. After confirming the diagnosis, methylprednisolone and oral prednisone were then administered with a favorable prognosis...Early recognition is crucial to minimize the need for unnecessary invasive procedures. The goal is to initiate the appropriate management as early as possible to optimize patient outcomes.
Journal
|
MUC16 (Mucin 16, Cell Surface Associated)
|
prednisone • hydroxychloroquine • methylprednisolone oral
1m
Idiopathic Multicentric Castleman Disease With Severe Eosinophilia and Diffuse Centrilobular Nodule-A Rare Case Report. (PubMed, Case Rep Hematol)
The patient declined cytotoxic chemotherapy and was treated with oral methylprednisolone (40 mg/day), which was gradually tapered to 10 mg/day...This case highlights a rare presentation of iMCD with eosinophilia and pulmonary involvement, emphasizing the importance of early recognition and timely corticosteroid therapy. Our report adds to the limited data on iMCD with eosinophilia and may help inform future clinical management.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL1B (Interleukin 1, beta)
|
methylprednisolone oral
2ms
Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis (clinicaltrials.gov)
P=N/A, N=30, Recruiting, Assiut University | Active, not recruiting --> Recruiting | Trial primary completion date: Sep 2025 --> Dec 2025
Enrollment open • Trial primary completion date
|
methylprednisolone oral • methylprednisolone sodium succinate
3ms
Retinoic Acid plus Hydroxychloroquine Sulfate and Methylprednisolone in Patients with Erosive Oral Lichen Planus: A Randomized and Controlled Clinical Trial (ChiCTR2500108290)
P4, N=146, Not yet recruiting, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; Shanghai Ninth People's Hospital, Shanghai JiaoTong University
New P4 trial
|
hydroxychloroquine • methylprednisolone oral
4ms
New P2 trial
|
methylprednisolone oral
5ms
Methylprednisolone Taper After Total Knee Replacement (clinicaltrials.gov)
P4, N=101, Completed, Emory University | Active, not recruiting --> Completed
Trial completion
|
dexamethasone injection • methylprednisolone oral
5ms
EASE-NMO: Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder (clinicaltrials.gov)
P2, N=0, Withdrawn, Tianjin Medical University General Hospital | N=75 --> 0 | Trial completion date: Dec 2025 --> Dec 2026 | Initiation date: Dec 2024 --> Sep 2025 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2025 --> Jun 2026
Enrollment change • Trial completion date • Trial initiation date • Trial withdrawal • Trial primary completion date
|
methylprednisolone oral
7ms
Organizing pneumonia in ALK+ non-small cell lung cancer treated with ceritinib: a case report. (PubMed, Discov Oncol)
OP should be considered when new lesions appear in the lungs of lung cancer patients, and distinguished from infectious pneumonia, metastasis, or cancer progression. In this respect, pathological biopsy plays an important role in diagnosis. In our case, discontinuation of ceritinib and regular steroid administration were effective.
Journal
|
ALK (Anaplastic lymphoma kinase)
|
ALK rearrangement
|
Zykadia (ceritinib) • Ensacove (ensartinib) • methylprednisolone oral
7ms
New P1 trial
|
methylprednisolone oral
7ms
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia (clinicaltrials.gov)
P=N/A, N=232, Recruiting, General Hospital of Shenyang Military Region | Not yet recruiting --> Recruiting
Enrollment open
|
Legalon (silibinin) • methylprednisolone oral
9ms
Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis (clinicaltrials.gov)
P=N/A, N=30, Active, not recruiting, Assiut University | Not yet recruiting --> Active, not recruiting | Trial completion date: Jun 2024 --> Nov 2025 | Trial primary completion date: Mar 2024 --> Sep 2025
Enrollment closed • Trial completion date • Trial primary completion date
|
methylprednisolone oral • methylprednisolone sodium succinate